tiprankstipranks
Advertisement
Advertisement
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Myriad Genetics to deliver six abstracts at AACR 2026
Premium
The Fly
Myriad Genetics to deliver six abstracts at AACR 2026
2M ago
Myriad Genetics announces FDA approval for MyChoice CDx Test
Premium
The Fly
Myriad Genetics announces FDA approval for MyChoice CDx Test
3M ago
Myriad Genetics price target lowered to $6 from $8 at UBS
PremiumThe FlyMyriad Genetics price target lowered to $6 from $8 at UBS
3M ago
Myriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
Premium
The Fly
Myriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
3M ago
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
Premium
Ratings
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
3M ago
Is MYGN a Buy, Before Earnings?
PremiumPre-EarningsIs MYGN a Buy, Before Earnings?
3M ago
Myriad announce publication of validation of FirstGene Multiple Prenatal Screen
Premium
The Fly
Myriad announce publication of validation of FirstGene Multiple Prenatal Screen
4M ago
Myriad Genetics management to meet with BTIG
Premium
The Fly
Myriad Genetics management to meet with BTIG
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100